NCT02106767View on ClinicalTrials.gov

The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 7, 2016

Study Completion Date

August 7, 2016

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Rosuvastatin 20mg po x1

DRUG

Rosuvastatin plus rifampin

Rifampin 600mg IV infused over 30 minutes followed by rosuvastatin 20mg PO x1

Trial Locations (1)

94143

CTSI Clinical Research Center, UCSF, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02106767 - The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin | Biotech Hunter | Biotech Hunter